Alzheimer’s Genetic Risk Score linked to Incident Mild Behavioral Impairment
Authors:
Preprint
Abstract
Mild Behavioral Impairment (MBI) describes the emergence of later-life Neuropsychiatric Symptoms (NPS) as an at-risk state for cognitive decline and dementia and as a potential manifestation of prodromal dementia. How NPS mechanistically link to the development of Mild Cognitive Impairment (MCI) and Alzheimer’s disease (AD) is not fully understood. Potential mechanisms include either shared risk factors that are related to both NPS and cognitive impairment, or AD pathology promoting NPS. This is the first study to examine whether AD genetic loci, individually and as a genetic risk score, are a shared risk factor with MBI. 1377 older adults (aged 72-79; 738 males; 763 normal cognition) from the PATH Through Life project. MBI was assessed in accordance with Criterion 1 of the ISTAART-AA diagnostic criteria using the Neuropsychiatric Inventory. 25 LOAD risk loci were genotyped and a weighted genetic risk score (GRS) was constructed. Binomial logistic regression adjusting for age, gender, and education examined the association between LOAD GRS and MBI domains. An increase in the LOAD GRS and APOE*ε4 were associated with higher likelihood of Affective Dysregulation; MS4A4A -rs4938933*C and MS4A6A -rs610932*G were associated with a reduced likelihood of Affective Dysregulation; ZCWPW1 -rs1476679*C was associated with a reduced likelihood of Social Inappropriateness and Abnormal Perception; BIN1 -rs744373*G and EPHA1 -rs11767557*C were associated with higher likelihood of Abnormal Perception; NME8 -rs2718058*G was associated with a reduced likelihood Decreased Motivation. These findings suggest a common genetic etiology between MBI and traditionally recognized memory problems observed in AD and improve our understanding of the pathophysiological features underlying MBI.Keywords
All Related Versions
This publication has 56 references indexed in Scilit:
- Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathologyMolecular Psychiatry, 2013
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapyNature Reviews Neurology, 2013
- Genome-wide association study of Alzheimer's disease with psychotic symptomsMolecular Psychiatry, 2011
- Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's diseaseNature Genetics, 2011
- Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's diseaseNature Genetics, 2011
- The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementiaInternational Psychogeriatrics, 2010
- Genome-wide Analysis of Genetic Loci Associated With Alzheimer DiseaseJAMA, 2010
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseNature Genetics, 2009
- Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene databaseNature Genetics, 2007
- The Neuropsychiatric InventoryNeurology, 1994